BMRN Biomarin Pharmaceutical Inc

Price (delayed)

$87.99

Market cap

$16.28B

P/E Ratio

419

Dividend/share

N/A

EPS

$0.21

Enterprise value

$16.75B

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and ...

Highlights
Biomarin Pharmaceutical's gross profit has increased by 8% YoY and by 2.7% QoQ
The equity has grown by 6% YoY and by 2.8% from the previous quarter
The net income has surged by 161% since the previous quarter but it has dropped by 95% year-on-year
Biomarin Pharmaceutical's EPS has surged by 160% QoQ but it has shrunk by 95% YoY

Key stats

What are the main financial stats of BMRN
Market
Shares outstanding
185M
Market cap
$16.28B
Enterprise value
$16.75B
Valuations
Price to earnings (P/E)
419
Price to book (P/B)
3.69
Price to sales (P/S)
8.61
EV/EBIT
328.81
EV/EBITDA
105.8
EV/Sales
8.91
Earnings
Revenue
$1.88B
EBIT
$50.95M
EBITDA
$158.35M
Free cash flow
$156.71M
Per share
EPS
$0.21
Free cash flow per share
$0.85
Book value per share
$23.86
Revenue per share
$10.22
TBVPS
$29.85
Balance sheet
Total assets
$6.06B
Total liabilities
$1.67B
Debt
$1.08B
Equity
$4.39B
Working capital
$1.9B
Liquidity
Debt to equity
0.25
Current ratio
4.88
Quick ratio
3.03
Net debt/EBITDA
3
Margins
EBITDA margin
8.4%
Gross margin
75.1%
Net margin
2.1%
Operating margin
1.6%
Efficiency
Return on assets
0.7%
Return on equity
0.9%
Return on invested capital
0.9%
Return on capital employed
0.9%
Return on sales
2.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BMRN stock price

How has the Biomarin Pharmaceutical stock price performed over time
Intraday
1.83%
1 week
6.18%
1 month
12.52%
1 year
5.96%
YTD
-0.41%
QTD
6.18%

Financial performance

How have Biomarin Pharmaceutical's revenue and profit performed over time
Revenue
$1.88B
Gross profit
$1.41B
Operating income
$29.9M
Net income
$39.35M
Gross margin
75.1%
Net margin
2.1%
The net income has surged by 161% since the previous quarter but it has dropped by 95% year-on-year
The net margin has soared by 160% since the previous quarter but it has dropped by 95% year-on-year
The operating income has surged by 136% since the previous quarter and by 126% year-on-year
Biomarin Pharmaceutical's operating margin has soared by 136% from the previous quarter and by 125% YoY

Growth

What is Biomarin Pharmaceutical's growth rate over time

Valuation

What is Biomarin Pharmaceutical stock price valuation
P/E
419
P/B
3.69
P/S
8.61
EV/EBIT
328.81
EV/EBITDA
105.8
EV/Sales
8.91
Biomarin Pharmaceutical's EPS has surged by 160% QoQ but it has shrunk by 95% YoY
The stock's price to book (P/B) is 23% less than its 5-year quarterly average of 4.7 but 3.4% more than its last 4 quarters average of 3.5
The equity has grown by 6% YoY and by 2.8% from the previous quarter
BMRN's price to sales (P/S) is 11% less than its 5-year quarterly average of 9.5 but 6% more than its last 4 quarters average of 8.0

Efficiency

How efficient is Biomarin Pharmaceutical business performance
Biomarin Pharmaceutical's ROIC has soared by 182% from the previous quarter and by 147% YoY
Biomarin Pharmaceutical's return on sales has surged by 182% QoQ and by 153% YoY
BMRN's return on assets has surged by 164% since the previous quarter but it has dropped by 95% year-on-year
The ROE has soared by 160% from the previous quarter but it has plunged by 96% YoY

Dividends

What is BMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BMRN.

Financial health

How did Biomarin Pharmaceutical financials performed over time
BMRN's quick ratio is up by 18% since the previous quarter but it is down by 12% year-on-year
The company's current ratio rose by 16% QoQ but it fell by 8% YoY
The debt is 75% smaller than the equity
The equity has grown by 6% YoY and by 2.8% from the previous quarter
BMRN's debt to equity is down by 3.8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.